@altonbrown While Ozempic/semaglutide has been used off label for weight loss, it has had substantial health benefits for pts with type 2 diabetes including better blood sugar control as well as heart protection in the setting of cardiovascular disease. ht
@OliveChirper @EricTopol This is even before you get to the broader argument involving softer data, including those involving MACE. https://t.co/eIIFtWdHhH https://t.co/0U9ky23xXm https://t.co/Pe944geFjX Among several others. Partner arguments can als
@assignedmedia @TomChivers Ozempic, in its original application as a diabetes drug, has suggested those kinds of benefits, yes. A major trial looking at its potential cardiac outcomes in those taking it for WL is expected to be released soon. https://t.co/
@statsguyuk Assuming the article is talking about semaglutide (it's paywalled for me), that was first launched as a diabetes drug and has shown some efficacy in heart disease e.g. https://t.co/pk9JuHZO7P